NEW HAVEN, Conn. and NANJING, China, Nov. 4, 2019 /PRNewswire/ -- Simcere Pharmaceutical Group and Aeromics, Inc. today announce collaboration and exclusive license agreement for AER-271, a clinical-stage anti-edema therapy, being developed for the treatment of stroke and other...
from PR Newswire: https://ift.tt/32de7pW
No comments:
Post a Comment